Work

Epidemiologic Analysis of Mortality Predictors and Readmissions in Patients with Transverse Myelitis and/or Acute Disseminated Encephalomyelitis: A Nationwide Readmissions Database Study

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background/Objectives: Transverse myelitis (TM) and acute disseminated encephalomyelitis (ADEM) are debilitating neurological conditions. We aimed to examine in-hospital mortality and readmissions in patients hospitalized with TM and/or ADEM. Methods: In this retrospective study, we analyzed the Nationwide Readmissions Database from 2010 to 2020, excluding 2015, to identify index hospitalizations for TM and/or ADEM. Patients were stratified according to in-hospital mortality status. We used the Pearson chi-square test and Wilcoxon rank-sum test to compare baseline characteristics, while multivariable logistic regression analysis was used to identify predictors of in-hospital mortality. Results: Of 50,357 patients hospitalized with TM and/or ADEM, 1236 (2.5%) did not survive index hospitalization. Nonsurvivors were older with longer lengths of stay and a higher comorbidity burden. Among those ≥45 years, there was a trend towards increased odds of in-hospital mortality. Infection-related factors were associated with increased odds of in-hospital mortality, including streptococcal infection (odds ratio [OR]: 5.45 [1.07–27.68], p = 0.04) and coronavirus disease 2019 (OR: 4.54 [2.51–8.19], p < 0.001). Stroke (OR 2.71 [2.11–3.48], p < 0.001) and congestive heart failure (OR 2.17 [1.66–2.85], p < 0.001) emerged as the strongest predictors amongst chronic comorbidities. Over the study period, 5301 (11.8%) patients were readmitted to the hospital within 30 days. Conclusions: In patients with TM and/or ADEM, in-hospital mortality was associated with older age, greater comorbidity burden, and concurrent infections, particularly COVID-19 and streptococcal infections. These findings highlight opportunities for prevention, early detection, and management strategies to improve outcomes for patients with TM and/or ADEM.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,930
OpenAlex ID: W7236092233
FWCI:
Cites: 24
Cited by:
Related to: 10